Understanding Ifosfamide Metabolism
Author Information
Author(s): EGC Brain, LJ Yu, K Gustafsson, P Drewes, DJ Waxman
Primary Institution: Boston University
Hypothesis
Can the balance between drug activation and inactivation of ifosfamide be modulated using P450 inducers and inhibitors?
Conclusion
The study demonstrates that specific P450 inducers and inhibitors can significantly alter the metabolism of ifosfamide, potentially improving its therapeutic use.
Supporting Evidence
- Induction of liver P450 2B enzymes significantly decreased the fraction of ifosfamide undergoing activation.
- Using metyrapone increased the total fraction of ifosfamide metabolized via the activation pathway.
- Dexamethasone treatment resulted in increased peak plasma concentrations of ifosfamide metabolites.
Takeaway
Ifosfamide is a cancer drug that can be changed in how it works by using other drugs that affect how it's processed in the body.
Methodology
The study used adult male Fischer 344 rats to investigate the effects of various P450 inducers and inhibitors on ifosfamide metabolism.
Limitations
The study was conducted in rats, which may not fully represent human metabolism.
Participant Demographics
Adult male Fischer 344 rats, aged 7-11 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website